These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 38680489)
1. Development of a visual Adhesion/Invasion Inhibition Assay to assess the functionality of Batani G; Vezzani G; Lashchuk S; Allaoui A; Cardamone D; Raso MM; Boero E; Roscioli E; Ridelfi M; Gasperini G; Pizza M; Rossi O; Berlanda Scorza F; Micoli F; Rappuoli R; Sala C Front Immunol; 2024; 15():1374293. PubMed ID: 38680489 [TBL] [Abstract][Full Text] [Related]
2. How Do the Virulence Factors of Mattock E; Blocker AJ Front Cell Infect Microbiol; 2017; 7():64. PubMed ID: 28393050 [No Abstract] [Full Text] [Related]
3. Shigella interaction with intestinal epithelial cells determines the innate immune response in shigellosis. Fernandez MI; Sansonetti PJ Int J Med Microbiol; 2003 Apr; 293(1):55-67. PubMed ID: 12755366 [TBL] [Abstract][Full Text] [Related]
4. Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput Nahm MH; Yu J; Weerts HP; Wenzel H; Tamilselvi CS; Chandrasekaran L; Pasetti MF; Mani S; Kaminski RW mSphere; 2018 Jun; 3(3):. PubMed ID: 29898979 [No Abstract] [Full Text] [Related]
5. Shigella Diversity and Changing Landscape: Insights for the Twenty-First Century. Anderson M; Sansonetti PJ; Marteyn BS Front Cell Infect Microbiol; 2016; 6():45. PubMed ID: 27148494 [TBL] [Abstract][Full Text] [Related]
6. A clinically parameterized mathematical model of Shigella immunity to inform vaccine design. Davis CL; Wahid R; Toapanta FR; Simon JK; Sztein MB PLoS One; 2018; 13(1):e0189571. PubMed ID: 29304144 [TBL] [Abstract][Full Text] [Related]
7. O-specific [corrected] polysaccharide conjugate vaccine-induced [corrected] antibodies prevent invasion of Shigella into Caco-2 cells and may be curative. Chowers Y; Kirschner J; Keller N; Barshack I; Bar-Meir S; Ashkenazi S; Schneerson R; Robbins J; Passwell JH Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2396-401. PubMed ID: 17287349 [TBL] [Abstract][Full Text] [Related]
10. Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination. Cohen D; Orr N; Robin G; Slepon R; Ashkenazi S; Ashkenazi I; Shemer J Clin Diagn Lab Immunol; 1996 Jul; 3(4):451-5. PubMed ID: 8807212 [TBL] [Abstract][Full Text] [Related]
11. The Multivalent Adhesion Molecule SSO1327 plays a key role in Shigella sonnei pathogenesis. Mahmoud RY; Stones DH; Li W; Emara M; El-Domany RA; Wang D; Wang Y; Krachler AM; Yu J Mol Microbiol; 2016 Feb; 99(4):658-73. PubMed ID: 26481305 [TBL] [Abstract][Full Text] [Related]
12. Applying mathematical tools to accelerate vaccine development: modeling Shigella immune dynamics. Davis CL; Wahid R; Toapanta FR; Simon JK; Sztein MB; Levy D PLoS One; 2013; 8(4):e59465. PubMed ID: 23589755 [TBL] [Abstract][Full Text] [Related]
13. Antibody response of monkeys to invasion plasmid antigen D after infection with Shigella spp. Oaks EV; Picking WD; Picking WL Clin Diagn Lab Immunol; 1996 Mar; 3(2):242-5. PubMed ID: 8991646 [TBL] [Abstract][Full Text] [Related]
14. Human Enteric α-Defensin 5 Promotes Shigella Infection by Enhancing Bacterial Adhesion and Invasion. Xu D; Liao C; Zhang B; Tolbert WD; He W; Dai Z; Zhang W; Yuan W; Pazgier M; Liu J; Yu J; Sansonetti PJ; Bevins CL; Shao Y; Lu W Immunity; 2018 Jun; 48(6):1233-1244.e6. PubMed ID: 29858013 [TBL] [Abstract][Full Text] [Related]